miRNA-200c和E-Cadherin在三阴性乳腺癌中的表达及意义
Expression and Clinical Significance of miRNA-200 and E-Cadherin in Triple Negative Breast Carcinoma
DOI: 10.12677/ACM.2023.131069, PDF,    科研立项经费支持
作者: 彭 湃, 郑 凯, 陈梦荷, 胡超华, 韩运涛*:武汉科技大学附属孝感医院普外科,湖北 孝感
关键词: 三阴性乳腺癌荧光定量PCR临床病理学转移TNBC Fluorescent Quantitation PCR Clinicopathology Metastasis
摘要: 目的:探讨miRNA-200c和E-cadherin在三阴性乳腺癌(TNBC)中的表达及临床意义。方法:用荧光定量PCR检测60例TNBC组织及50例正常乳腺组织中miRNA-200c和E-cadherin的表达,分析其表达与TNBC临床病理特征的关系。结果:miRNA-200c和E-cadherin在TNBC组织中的表达水低于正常乳腺组织(P < 0.05),其表达与TNBC的临床分期、组织学分级及淋巴结转移相关(P < 0.05)。miRNA-200c和E-cadherin在TNBC中的表达呈正相关(P < 0.05)。结论:miRNA-200c和E-cadherin可能参与TNBC的进展及转移过程,可能成为新的肿瘤标志物。
Abstract: Objective: To investigate the expression and clinical significance of miRNA-200c and E-cadherin in triple negative breast cancer (TNBC). Methods: The expression of miRNA-200c and E-cadherinin in 60 TNBC tissues and 50 normal tissues was detected by fluorescent quantitation PCR, and the cor-relation between its expression and clinicopathological features of TNBC was analyzed. Results: The expression level of miRNA-200and E-cadherinin in TNBC tissue was significantly lower than that in normal breast tissue (P < 0.05), and its expression was correlated with lymph node metastasis, tu-mor stage, histological grade in TNBC tissue (P < 0.05). There was a positive correlation between miRNA-200c and E-cadherin expression in TNBC (P < 0.05). Conclusions: miRNA-200c and E-cadherin may be involved in the development and metastasis of TNBC, and may become new tu-mor markers.
文章引用:彭湃, 郑凯, 陈梦荷, 胡超华, 韩运涛. miRNA-200c和E-Cadherin在三阴性乳腺癌中的表达及意义[J]. 临床医学进展, 2023, 13(1): 467-473. https://doi.org/10.12677/ACM.2023.131069

参考文献

[1] 吴至佛, 汪灵, 黄俊辉. 三阴性乳腺癌的生物标记物研究进展[J]. 中国普通外科杂志, 2017, 26(11): 1472-1477.
[2] 张继博, 史业辉, 贾勇圣, 佟仲生. 三阴性乳腺癌治疗进展[J]. 肿瘤, 2017, 37(7): 788-794.
[3] 刘子梅, 沈赞. 三阴性乳腺癌靶向治疗最新进展[J]. 中国癌症杂志, 2017, 27(1): 36-40.
[4] 三阴性乳腺癌辅助治进展[J]. 中国肿瘤临床, 2022, 49(9): 473.
[5] 杨晓冉, 闫慧姣, 王佳玉, 等. 2012-2014年全国多中心术后复发三阴性乳腺癌临床流行病学研究[J]. 肿瘤学杂志, 2021, 27(12): 979-985.
[6] Le, T.D., Liu, L., Tsykin, A., et al. (2013) Inferring microRNA-mRNA Causal Regulatory Relationships from Expression Data. Bioinformatics, 29, 765-771. [Google Scholar] [CrossRef] [PubMed]
[7] Ambros, V. (2001) microRNAs: Tiny Regulators with Great Potential. Cell, 107, 823-826. [Google Scholar] [CrossRef
[8] 陶陶. EZH2通过靶向抑制miR-200c和miR-181b促进前列腺癌细胞增殖和糖代谢[D]: [博士学位论文]. 南京: 东南大学, 2016.
[9] 窦维佳, 王景杰, 刘震雄. miR-200b和miR-200c在结肠癌组织中的表达及其临床病理学意义[J]. 山西医科大学学报, 2018, 49(1): 11-14.
[10] 周欣亮, 王玉栋, 张难, 等. 胃癌组织TGF-β对miR-200c/141表达影响的研究[J]. 中华肿瘤防治杂志, 2017, 24(8): 552-556.
[11] 王培云, 张海洋, 邓婷, 等. miR-200b、miR-200c靶向肝细胞生长因子抑制结直肠癌细胞增殖的机制研究[J]. 肿瘤综合治疗电子杂志, 2020, 6(2): 96-101.
[12] Bruner, H.C. and Derksen, P.W.B. (2018) Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer. Cold Spring Harbor Per-spectives in Biology, 10, a029330. [Google Scholar] [CrossRef] [PubMed]
[13] Lecuit, T. and Yap, A.S. (2015) E-Cadherin Junctions as Active Mechanical Integrators in Tissue Dynamics. Nature Cell Biology, 17, 533-539. [Google Scholar] [CrossRef] [PubMed]
[14] 杨森果, 毛大华, 杨海松, 等. E-cadherin与肿瘤侵袭、转移相关性研究进展[J]. 医学信息, 2018, 31(3): 3-6.
[15] 彭湃, 胡超华, 韩运涛, 等. CD97异构体在结肠癌组织中的表达及其临床意义[J]. 肿瘤研究与临床, 2019(10): 662-665.
[16] 徐泰. miRNA-639在乳腺癌中表达及其意义[J]. 中国普通外科杂志, 2014, 23(11): 1506-1511.
[17] 张诗蒙, 刘非, 尹小毛, 郑磊, 王前. miRNA-27b抑制PPARγ促进乳腺癌细胞增殖[J]. 实用医学杂志, 2014, 30(8): 1182-1184.
[18] 骆广涛, 王本忠. miRNA-4465过表达对乳腺癌MDA-MB-231细胞迁移侵袭的影响及其机制[J]. 安徽医科大学学报, 2015(11): 1570-1574.
[19] 辛海娜, 姜丹丹, 吕志栋, 孙苏园, 孔吉霖, 李福年. miRNA-135b靶向作用于APC对三阴型乳腺癌细胞增殖、侵袭及迁移的影响[J]. 中华医学杂志, 2015, 95(30): 2474-2477.
[20] Liu, X., Zhang, J., Xie, B., et al. (2016) MicroRNA-200 Family Profile: A Promising Ancillary Tool for Accurate Cancer Diagnosis. American Journal of Therapeutics, 23, e388-e397. [Google Scholar] [CrossRef
[21] Ceppi, P., Mudduluru, G., Kumarswamy, R., et al. (2010) Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer. Molecular Cancer Research, 8, 1207-1216. [Google Scholar] [CrossRef
[22] Paterson, E.L., Kazenwadel, J., Bert, A.G., et al. (2013) Down-Regulation of the miRNA-200 Family at the Invasive Front of Colorectal Cancers with degraded basement mem-brane indicates EMT Is Involved in Cancer Progression. Neoplasia, 15, 180-191. [Google Scholar] [CrossRef] [PubMed]
[23] Katz, B., Reis, S.T., Viana, N.I., et al. (2014) Comprehensive Study of Gene and microRNA Expression Related to Epithelial-Mesenchymal Transition in Prostate Cancer. PLOS ONE, 9, e113700. [Google Scholar] [CrossRef] [PubMed]
[24] Minn, Y.K., Lee, D.H., Hyung, W.J., et al. (2014) Mi-croRNA-200 Family Members and ZEB2 Are Associated with Brain Metastasis in Gastric Adenocarcinoma. Interna-tional Journal of Oncology, 45, 2403-2410. [Google Scholar] [CrossRef] [PubMed]
[25] Brozovic, A., Duran, G.E., Wang, Y.C., et al. (2015) The miR-200 Family Differentially Regulates Sensitivity to Paclitaxel and Carboplatin in Human Ovarian Carcinoma OVCAR-3 and MES-OV Cells. Molecular Oncology, 9, 1678-1693. [Google Scholar] [CrossRef] [PubMed]
[26] 徐江锋, 罗庚求. 上皮细胞间质转型与肿瘤转移[J]. 国际病理科学与临床杂志, 2007, 27(5): 393-396.
[27] 任弘毅, 王艳霞, 吴江. 上皮-间质转化与肿瘤转移的相关进展[J]. 四川解剖学杂志, 2012, 20(1): 27-31+35.
[28] 张青云, 傅俊江, 陈汉春. 上皮间质转化介导肿瘤转移的分子机制[J]. 生命科学研究, 2018, 22(6): 503-510.
[29] 张韬, 赖钦声, 毛驰. E-Cadherin与肿瘤转移[J]. 口腔颌面外科杂志, 1999, 9(3): 40-42+65.
[30] 桂德春, 李小冬, 江平, 等. P120ctn/E-cadherin与肿瘤关系的研究[J]. 吉林医学, 2014, 35(30): 6768-6769.